Bone Growth Stimulators Market
The market for bone growth stimulators is set to grow to $1.94 billion by 2030, with a projected CAGR of 4.9% from 2023. Delve into the latest trends and forecasts.n
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
What Key Trends Are Driving the Bone Growth Stimulators Market to Be Worth $1.94 Billion by 2030?
Bone Growth StimulatorsMarket2023-2030 Meticulous Research , a prominent market research company, has published an insightful report titled Bone Growth Stimulators Market by Product (Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet Rich Plasma), Application (Spinal Fusion, Fracture, Oral Surgeries), End User (Hospital, ASC) - Global Forecast to 2030. This comprehensive analysis outlines the market dynamics, trends, and forecasts for the bone growth stimulators market. Request for Sample Report:https://www.meticulousresearch.com/request-sample- report/cp_id=3530? Market Projections According to the latest findings from Meticulous Research , the bone growth stimulators market is expected to achieve $1.94 billion by 2030, with a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. This anticipated growth is driven by several factors, including the increasing preference for minimally invasive treatments, a rise in bone fractures and spinal injuries, and a growing geriatric population experiencing orthopedic diseases and injuries. Additionally, the rising incidents of sports-related injuries are propelling market expansion. Opportunities for Growth The bone growth stimulators market also benefits from the increasing number of hospitals and surgical centers globally, alongside the growing utilization of platelet-rich plasma (PRP) in diverse medical applications. Emerging economies are further contributing to the potential for market growth, highlighting numerous opportunities for stakeholders in this sector. Segmentation by Product The bone growth stimulators market is segmented into several categories, including Product (Bone Growth Stimulation Devices [External Bone Growth Stimulators: Capacitive Coupling Devices, Combined Magnetic Field Devices, and Pulsed Electromagnetic Field Devices], Ultrasonic Bone Growth Stimulators, Implantable Bone Growth Stimulators), Application (Spinal Fusion Surgeries, Union & Non-union Bone Fractures, Oral and Maxillofacial Surgeries, and Other Applications), End User (Hospitals & Specialized Clinics, Ambulatory Surgery Centers, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). Dominance of Bone Growth Stimulation Devices In 2023, the segment for bone growth stimulation devices is anticipated to hold the largest share of the overall market. These devices play a crucial role in promoting bone healing for fractures. The significant market share for this segment can be attributed to the rising incidence of bone fractures, an increasing demand for cost-effective and less painful treatments, and a preference for non-invasive or minimally invasive surgical interventions. Growing Segment of Delayed Union & Non-Union Bone Fractures Among applications, the delayed union & non-union bone fractures segment is projected to Page 1 of 3 Meticulous Research| sales@meticulousresearch.com
Bone Growth StimulatorsMarket2023-2030 witness the highest CAGR throughout the forecast period. This growth is primarily due to an increase in bone fractures among the geriatric population, who often face orthopedic challenges. The occurrence of delayed union and non-union fractures is often linked to inadequate nutrition and blood supply to the affected areas. Significance of Healthcare Spending A report from the International Osteoporosis Foundation indicates that osteoporosis leads to around 4.3 million fragility fractures and incurs healthcare costs close to $59.012 million ( 56 billion) annually in Europe. As the demographic of individuals aged 75 and over continues to grow, an estimated 29% of women and 42% of men will experience osteoporotic fractures between 2019 and 2034, resulting in a significant rise in treatment demands. End-User Market Dynamics Focusing on end-users, the hospitals and specialized clinics segment is expected to dominate the market share in 2023. This is due to the widespread availability of hospitals across urban and rural regions, an increase in patients seeking treatment for various conditions, and a rising number of healthcare professionals, including doctors and surgeons. North America s Market Leadership In terms of geography, North America is projected to hold the largest market share for bone growth stimulators in 2023. The region's dominance can be attributed to high healthcare expenditure, a growing elderly population, advancements in medical technology, and a robust adoption rate of innovative healthcare products. Key Players in the Market Several key companies are making significant contributions to the bone growth stimulators market, including Orthofix Medical Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), DJO, LLC (U.S.), Bioventus LLC (U.S.), OssaTechnics BV (Germany), Arthrex GmbH (U.S.), Smith & Nephew plc (U.K.), and ITO CO., Ltd. (Japan). These companies are instrumental in driving innovation and expanding the market through new product development and strategic partnerships. Buy Now: https://www.meticulousresearch.com/Checkout/73200843? About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention Page 2 of 3 Meticulous Research| sales@meticulousresearch.com
Bone Growth StimulatorsMarket2023-2030 to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com
